Fluorine in PDB 8uvq: Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down)
Enzymatic activity of Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down)
All present enzymatic activity of Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down):
3.6.4.6;
Fluorine Binding Sites:
Pages:
>>> Page 1 <<<
Page 2, Binding sites: 11 -
12;
Binding sites:
The binding sites of Fluorine atom in the Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down)
(pdb code 8uvq). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 12 binding sites of Fluorine where determined in the
Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down), PDB code: 8uvq:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
9;
10;
Fluorine binding site 1 out
of 12 in 8uvq
Go back to
Fluorine Binding Sites List in 8uvq
Fluorine binding site 1 out
of 12 in the Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F903
b:75.6
occ:1.00
|
F20
|
A:XO8903
|
0.0
|
75.6
|
1.0
|
C19
|
A:XO8903
|
1.3
|
76.7
|
1.0
|
C21
|
A:XO8903
|
2.3
|
76.6
|
1.0
|
C18
|
A:XO8903
|
2.3
|
76.5
|
1.0
|
O22
|
A:XO8903
|
2.8
|
74.5
|
1.0
|
CB
|
A:LYS615
|
3.2
|
68.2
|
1.0
|
C42
|
A:XO8903
|
3.6
|
77.7
|
1.0
|
CA
|
A:LYS615
|
3.6
|
68.4
|
1.0
|
C17
|
A:XO8903
|
3.7
|
77.9
|
1.0
|
CG
|
A:PRO510
|
3.9
|
75.7
|
1.0
|
C43
|
A:XO8903
|
4.0
|
79.3
|
1.0
|
CD
|
A:LYS512
|
4.2
|
71.9
|
1.0
|
C23
|
A:XO8903
|
4.2
|
73.9
|
1.0
|
CE
|
A:LYS615
|
4.3
|
67.9
|
1.0
|
C37
|
A:XO8903
|
4.4
|
72.1
|
1.0
|
CG
|
A:LYS615
|
4.5
|
69.3
|
1.0
|
N
|
A:LYS615
|
4.5
|
68.0
|
1.0
|
CD
|
A:PRO510
|
4.7
|
76.8
|
1.0
|
C
|
A:LYS615
|
4.8
|
68.9
|
1.0
|
N38
|
A:XO8903
|
4.8
|
70.9
|
1.0
|
O
|
A:LYS615
|
4.9
|
70.3
|
1.0
|
C16
|
A:XO8903
|
4.9
|
79.3
|
1.0
|
CD
|
A:LYS615
|
4.9
|
67.0
|
1.0
|
|
Fluorine binding site 2 out
of 12 in 8uvq
Go back to
Fluorine Binding Sites List in 8uvq
Fluorine binding site 2 out
of 12 in the Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F903
b:82.0
occ:1.00
|
F44
|
A:XO8903
|
0.0
|
82.0
|
1.0
|
C43
|
A:XO8903
|
1.3
|
79.3
|
1.0
|
C42
|
A:XO8903
|
2.3
|
77.7
|
1.0
|
C17
|
A:XO8903
|
2.3
|
77.9
|
1.0
|
C16
|
A:XO8903
|
2.9
|
79.3
|
1.0
|
C01
|
A:XO8903
|
3.2
|
80.1
|
1.0
|
C18
|
A:XO8903
|
3.6
|
76.5
|
1.0
|
C21
|
A:XO8903
|
3.6
|
76.6
|
1.0
|
O
|
A:PRO500
|
3.7
|
87.2
|
1.0
|
CB
|
A:PRO500
|
3.8
|
83.1
|
1.0
|
CB
|
A:PHE503
|
4.0
|
84.0
|
1.0
|
N15
|
A:XO8903
|
4.0
|
80.9
|
1.0
|
C19
|
A:XO8903
|
4.0
|
76.7
|
1.0
|
CA
|
A:PRO500
|
4.1
|
83.6
|
1.0
|
C
|
A:PRO500
|
4.3
|
85.4
|
1.0
|
N02
|
A:XO8903
|
4.4
|
82.5
|
1.0
|
CD
|
A:PRO510
|
4.5
|
76.8
|
1.0
|
CG
|
A:PRO510
|
4.5
|
75.7
|
1.0
|
O
|
A:PRO496
|
4.6
|
78.5
|
1.0
|
N
|
A:LEU504
|
4.6
|
88.8
|
1.0
|
N03
|
A:XO8903
|
4.7
|
83.3
|
1.0
|
O22
|
A:XO8903
|
4.8
|
74.5
|
1.0
|
C
|
A:PHE503
|
4.9
|
87.9
|
1.0
|
CB
|
A:LEU504
|
4.9
|
87.3
|
1.0
|
CG
|
A:PHE503
|
4.9
|
83.3
|
1.0
|
C23
|
A:XO8903
|
5.0
|
73.9
|
1.0
|
CA
|
A:PHE503
|
5.0
|
86.0
|
1.0
|
|
Fluorine binding site 3 out
of 12 in 8uvq
Go back to
Fluorine Binding Sites List in 8uvq
Fluorine binding site 3 out
of 12 in the Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F903
b:38.7
occ:1.00
|
F20
|
B:XO8903
|
0.0
|
38.7
|
1.0
|
C19
|
B:XO8903
|
1.3
|
38.9
|
1.0
|
C21
|
B:XO8903
|
2.3
|
39.9
|
1.0
|
C18
|
B:XO8903
|
2.3
|
35.7
|
1.0
|
O22
|
B:XO8903
|
2.8
|
35.7
|
1.0
|
CB
|
B:LYS615
|
3.2
|
27.2
|
1.0
|
C42
|
B:XO8903
|
3.6
|
39.8
|
1.0
|
CA
|
B:LYS615
|
3.6
|
27.5
|
1.0
|
C17
|
B:XO8903
|
3.7
|
38.9
|
1.0
|
CG
|
B:PRO510
|
3.9
|
36.3
|
1.0
|
C43
|
B:XO8903
|
4.0
|
41.7
|
1.0
|
CD
|
B:LYS512
|
4.2
|
34.1
|
1.0
|
C23
|
B:XO8903
|
4.2
|
33.7
|
1.0
|
CE
|
B:LYS615
|
4.3
|
30.6
|
1.0
|
C37
|
B:XO8903
|
4.4
|
29.4
|
1.0
|
N
|
B:LYS615
|
4.5
|
24.0
|
1.0
|
CG
|
B:LYS615
|
4.5
|
32.7
|
1.0
|
CD
|
B:PRO510
|
4.6
|
36.8
|
1.0
|
C
|
B:LYS615
|
4.8
|
28.8
|
1.0
|
N38
|
B:XO8903
|
4.8
|
25.3
|
1.0
|
O
|
B:LYS615
|
4.9
|
31.6
|
1.0
|
C16
|
B:XO8903
|
4.9
|
42.1
|
1.0
|
CD
|
B:LYS615
|
4.9
|
29.3
|
1.0
|
|
Fluorine binding site 4 out
of 12 in 8uvq
Go back to
Fluorine Binding Sites List in 8uvq
Fluorine binding site 4 out
of 12 in the Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F903
b:45.7
occ:1.00
|
F44
|
B:XO8903
|
0.0
|
45.7
|
1.0
|
C43
|
B:XO8903
|
1.3
|
41.7
|
1.0
|
C42
|
B:XO8903
|
2.3
|
39.8
|
1.0
|
C17
|
B:XO8903
|
2.3
|
38.9
|
1.0
|
C16
|
B:XO8903
|
2.9
|
42.1
|
1.0
|
C01
|
B:XO8903
|
3.2
|
41.9
|
1.0
|
C18
|
B:XO8903
|
3.6
|
35.7
|
1.0
|
C21
|
B:XO8903
|
3.6
|
39.9
|
1.0
|
O
|
B:PRO500
|
3.7
|
52.0
|
1.0
|
CB
|
B:PRO500
|
3.8
|
44.9
|
1.0
|
CB
|
B:PHE503
|
4.0
|
44.0
|
1.0
|
N15
|
B:XO8903
|
4.0
|
41.4
|
1.0
|
C19
|
B:XO8903
|
4.0
|
38.9
|
1.0
|
CA
|
B:PRO500
|
4.1
|
44.0
|
1.0
|
C
|
B:PRO500
|
4.3
|
46.4
|
1.0
|
N02
|
B:XO8903
|
4.4
|
43.7
|
1.0
|
CD
|
B:PRO510
|
4.5
|
36.8
|
1.0
|
CG
|
B:PRO510
|
4.5
|
36.3
|
1.0
|
O
|
B:PRO496
|
4.6
|
43.0
|
1.0
|
N
|
B:LEU504
|
4.6
|
54.2
|
1.0
|
N03
|
B:XO8903
|
4.7
|
44.6
|
1.0
|
O22
|
B:XO8903
|
4.8
|
35.7
|
1.0
|
C
|
B:PHE503
|
4.8
|
53.2
|
1.0
|
CB
|
B:LEU504
|
4.9
|
51.3
|
1.0
|
CG
|
B:PHE503
|
5.0
|
44.6
|
1.0
|
C23
|
B:XO8903
|
5.0
|
33.7
|
1.0
|
CA
|
B:PHE503
|
5.0
|
48.8
|
1.0
|
|
Fluorine binding site 5 out
of 12 in 8uvq
Go back to
Fluorine Binding Sites List in 8uvq
Fluorine binding site 5 out
of 12 in the Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:F903
b:36.3
occ:1.00
|
F20
|
C:XO8903
|
0.0
|
36.3
|
1.0
|
C19
|
C:XO8903
|
1.3
|
35.1
|
1.0
|
C21
|
C:XO8903
|
2.3
|
37.4
|
1.0
|
C18
|
C:XO8903
|
2.3
|
35.6
|
1.0
|
O22
|
C:XO8903
|
2.8
|
37.9
|
1.0
|
CB
|
C:LYS615
|
3.2
|
25.4
|
1.0
|
C42
|
C:XO8903
|
3.6
|
37.2
|
1.0
|
CA
|
C:LYS615
|
3.6
|
23.7
|
1.0
|
C17
|
C:XO8903
|
3.7
|
38.9
|
1.0
|
CG
|
C:PRO510
|
3.9
|
31.0
|
1.0
|
C43
|
C:XO8903
|
4.0
|
39.3
|
1.0
|
CD
|
C:LYS512
|
4.2
|
28.9
|
1.0
|
C23
|
C:XO8903
|
4.2
|
33.4
|
1.0
|
CE
|
C:LYS615
|
4.3
|
30.9
|
1.0
|
C37
|
C:XO8903
|
4.4
|
24.9
|
1.0
|
N
|
C:LYS615
|
4.5
|
22.6
|
1.0
|
CG
|
C:LYS615
|
4.5
|
30.1
|
1.0
|
CD
|
C:PRO510
|
4.6
|
35.3
|
1.0
|
C
|
C:LYS615
|
4.8
|
27.2
|
1.0
|
N38
|
C:XO8903
|
4.8
|
24.2
|
1.0
|
O
|
C:LYS615
|
4.9
|
31.8
|
1.0
|
C16
|
C:XO8903
|
4.9
|
39.6
|
1.0
|
CD
|
C:LYS615
|
4.9
|
31.1
|
1.0
|
|
Fluorine binding site 6 out
of 12 in 8uvq
Go back to
Fluorine Binding Sites List in 8uvq
Fluorine binding site 6 out
of 12 in the Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:F903
b:42.6
occ:1.00
|
F44
|
C:XO8903
|
0.0
|
42.6
|
1.0
|
C43
|
C:XO8903
|
1.3
|
39.3
|
1.0
|
C42
|
C:XO8903
|
2.3
|
37.2
|
1.0
|
C17
|
C:XO8903
|
2.3
|
38.9
|
1.0
|
C16
|
C:XO8903
|
2.9
|
39.6
|
1.0
|
C01
|
C:XO8903
|
3.2
|
39.0
|
1.0
|
C18
|
C:XO8903
|
3.6
|
35.6
|
1.0
|
C21
|
C:XO8903
|
3.6
|
37.4
|
1.0
|
O
|
C:PRO500
|
3.7
|
45.9
|
1.0
|
CB
|
C:PRO500
|
3.8
|
41.8
|
1.0
|
CB
|
C:PHE503
|
4.0
|
40.6
|
1.0
|
N15
|
C:XO8903
|
4.0
|
38.7
|
1.0
|
C19
|
C:XO8903
|
4.0
|
35.1
|
1.0
|
CA
|
C:PRO500
|
4.1
|
40.5
|
1.0
|
C
|
C:PRO500
|
4.3
|
43.7
|
1.0
|
N02
|
C:XO8903
|
4.4
|
40.9
|
1.0
|
CD
|
C:PRO510
|
4.5
|
35.3
|
1.0
|
CG
|
C:PRO510
|
4.5
|
31.0
|
1.0
|
O
|
C:PRO496
|
4.6
|
35.8
|
1.0
|
N
|
C:LEU504
|
4.6
|
48.2
|
1.0
|
N03
|
C:XO8903
|
4.7
|
42.6
|
1.0
|
O22
|
C:XO8903
|
4.8
|
37.9
|
1.0
|
C
|
C:PHE503
|
4.8
|
47.4
|
1.0
|
CB
|
C:LEU504
|
4.9
|
46.3
|
1.0
|
CG
|
C:PHE503
|
4.9
|
39.5
|
1.0
|
CA
|
C:PHE503
|
5.0
|
45.8
|
1.0
|
C23
|
C:XO8903
|
5.0
|
33.4
|
1.0
|
|
Fluorine binding site 7 out
of 12 in 8uvq
Go back to
Fluorine Binding Sites List in 8uvq
Fluorine binding site 7 out
of 12 in the Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 7 of Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:F903
b:75.7
occ:1.00
|
F20
|
D:XO8903
|
0.0
|
75.7
|
1.0
|
C19
|
D:XO8903
|
1.3
|
77.4
|
1.0
|
C21
|
D:XO8903
|
2.3
|
77.5
|
1.0
|
C18
|
D:XO8903
|
2.3
|
77.6
|
1.0
|
O22
|
D:XO8903
|
2.8
|
75.3
|
1.0
|
CB
|
D:LYS615
|
3.2
|
68.7
|
1.0
|
C42
|
D:XO8903
|
3.6
|
78.4
|
1.0
|
CA
|
D:LYS615
|
3.6
|
68.4
|
1.0
|
C17
|
D:XO8903
|
3.7
|
79.1
|
1.0
|
CG
|
D:PRO510
|
3.9
|
76.2
|
1.0
|
C43
|
D:XO8903
|
4.0
|
79.9
|
1.0
|
CD
|
D:LYS512
|
4.2
|
71.8
|
1.0
|
C23
|
D:XO8903
|
4.2
|
74.5
|
1.0
|
CE
|
D:LYS615
|
4.3
|
68.7
|
1.0
|
C37
|
D:XO8903
|
4.4
|
72.6
|
1.0
|
CG
|
D:LYS615
|
4.5
|
69.7
|
1.0
|
N
|
D:LYS615
|
4.5
|
68.1
|
1.0
|
CD
|
D:PRO510
|
4.6
|
77.3
|
1.0
|
C
|
D:LYS615
|
4.8
|
69.0
|
1.0
|
N38
|
D:XO8903
|
4.8
|
71.1
|
1.0
|
O
|
D:LYS615
|
4.9
|
70.4
|
1.0
|
C16
|
D:XO8903
|
4.9
|
80.5
|
1.0
|
CD
|
D:LYS615
|
4.9
|
67.6
|
1.0
|
|
Fluorine binding site 8 out
of 12 in 8uvq
Go back to
Fluorine Binding Sites List in 8uvq
Fluorine binding site 8 out
of 12 in the Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 8 of Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:F903
b:82.2
occ:1.00
|
F44
|
D:XO8903
|
0.0
|
82.2
|
1.0
|
C43
|
D:XO8903
|
1.3
|
79.9
|
1.0
|
C42
|
D:XO8903
|
2.3
|
78.4
|
1.0
|
C17
|
D:XO8903
|
2.3
|
79.1
|
1.0
|
C16
|
D:XO8903
|
2.9
|
80.5
|
1.0
|
C01
|
D:XO8903
|
3.2
|
81.0
|
1.0
|
C18
|
D:XO8903
|
3.6
|
77.6
|
1.0
|
C21
|
D:XO8903
|
3.6
|
77.5
|
1.0
|
O
|
D:PRO500
|
3.7
|
87.7
|
1.0
|
CB
|
D:PRO500
|
3.8
|
83.1
|
1.0
|
CB
|
D:PHE503
|
4.0
|
84.8
|
1.0
|
N15
|
D:XO8903
|
4.0
|
81.7
|
1.0
|
C19
|
D:XO8903
|
4.0
|
77.4
|
1.0
|
CA
|
D:PRO500
|
4.1
|
83.6
|
1.0
|
C
|
D:PRO500
|
4.3
|
85.7
|
1.0
|
N02
|
D:XO8903
|
4.4
|
83.7
|
1.0
|
CD
|
D:PRO510
|
4.5
|
77.3
|
1.0
|
CG
|
D:PRO510
|
4.5
|
76.2
|
1.0
|
O
|
D:PRO496
|
4.6
|
79.1
|
1.0
|
N
|
D:LEU504
|
4.6
|
89.7
|
1.0
|
N03
|
D:XO8903
|
4.7
|
84.3
|
1.0
|
O22
|
D:XO8903
|
4.8
|
75.3
|
1.0
|
C
|
D:PHE503
|
4.8
|
88.7
|
1.0
|
CB
|
D:LEU504
|
4.9
|
88.2
|
1.0
|
CG
|
D:PHE503
|
4.9
|
84.1
|
1.0
|
CA
|
D:PHE503
|
5.0
|
86.7
|
1.0
|
C23
|
D:XO8903
|
5.0
|
74.5
|
1.0
|
|
Fluorine binding site 9 out
of 12 in 8uvq
Go back to
Fluorine Binding Sites List in 8uvq
Fluorine binding site 9 out
of 12 in the Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 9 of Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
E:F903
b:42.5
occ:1.00
|
F20
|
E:XO8903
|
0.0
|
42.5
|
1.0
|
C19
|
E:XO8903
|
1.3
|
43.3
|
1.0
|
C21
|
E:XO8903
|
2.3
|
43.9
|
1.0
|
C18
|
E:XO8903
|
2.3
|
42.4
|
1.0
|
O22
|
E:XO8903
|
2.8
|
41.2
|
1.0
|
CB
|
E:LYS615
|
3.2
|
35.7
|
1.0
|
C42
|
E:XO8903
|
3.6
|
44.8
|
1.0
|
CA
|
E:LYS615
|
3.6
|
36.0
|
1.0
|
C17
|
E:XO8903
|
3.7
|
44.7
|
1.0
|
CG
|
E:PRO510
|
3.9
|
43.5
|
1.0
|
C43
|
E:XO8903
|
4.0
|
46.4
|
1.0
|
CD
|
E:LYS512
|
4.2
|
40.7
|
1.0
|
C23
|
E:XO8903
|
4.2
|
40.3
|
1.0
|
CE
|
E:LYS615
|
4.3
|
35.2
|
1.0
|
C37
|
E:XO8903
|
4.4
|
37.5
|
1.0
|
N
|
E:LYS615
|
4.5
|
34.2
|
1.0
|
CG
|
E:LYS615
|
4.5
|
38.5
|
1.0
|
CD
|
E:PRO510
|
4.6
|
44.5
|
1.0
|
C
|
E:LYS615
|
4.8
|
36.6
|
1.0
|
N38
|
E:XO8903
|
4.8
|
35.6
|
1.0
|
O
|
E:LYS615
|
4.9
|
38.6
|
1.0
|
C16
|
E:XO8903
|
4.9
|
47.4
|
1.0
|
CD
|
E:LYS615
|
4.9
|
35.3
|
1.0
|
|
Fluorine binding site 10 out
of 12 in 8uvq
Go back to
Fluorine Binding Sites List in 8uvq
Fluorine binding site 10 out
of 12 in the Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 10 of Human P97/Vcp R155H Mutant Structure with A Triazole Inhibitor (NSC819701/Down) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
E:F903
b:49.4
occ:1.00
|
F44
|
E:XO8903
|
0.0
|
49.4
|
1.0
|
C43
|
E:XO8903
|
1.3
|
46.4
|
1.0
|
C42
|
E:XO8903
|
2.3
|
44.8
|
1.0
|
C17
|
E:XO8903
|
2.3
|
44.7
|
1.0
|
C16
|
E:XO8903
|
2.9
|
47.4
|
1.0
|
C01
|
E:XO8903
|
3.2
|
48.3
|
1.0
|
C18
|
E:XO8903
|
3.6
|
42.4
|
1.0
|
C21
|
E:XO8903
|
3.6
|
43.9
|
1.0
|
O
|
E:PRO500
|
3.7
|
55.7
|
1.0
|
CB
|
E:PRO500
|
3.8
|
51.2
|
1.0
|
CB
|
E:PHE503
|
4.0
|
51.1
|
1.0
|
N15
|
E:XO8903
|
4.0
|
47.1
|
1.0
|
C19
|
E:XO8903
|
4.0
|
43.3
|
1.0
|
CA
|
E:PRO500
|
4.1
|
50.7
|
1.0
|
C
|
E:PRO500
|
4.3
|
52.4
|
1.0
|
N02
|
E:XO8903
|
4.4
|
49.7
|
1.0
|
CD
|
E:PRO510
|
4.5
|
44.5
|
1.0
|
CG
|
E:PRO510
|
4.5
|
43.5
|
1.0
|
O
|
E:PRO496
|
4.6
|
48.0
|
1.0
|
N
|
E:LEU504
|
4.6
|
57.1
|
1.0
|
N03
|
E:XO8903
|
4.7
|
49.5
|
1.0
|
O22
|
E:XO8903
|
4.8
|
41.2
|
1.0
|
C
|
E:PHE503
|
4.8
|
56.7
|
1.0
|
CB
|
E:LEU504
|
4.9
|
55.7
|
1.0
|
CG
|
E:PHE503
|
4.9
|
51.2
|
1.0
|
C23
|
E:XO8903
|
5.0
|
40.3
|
1.0
|
CA
|
E:PHE503
|
5.0
|
54.2
|
1.0
|
|
Reference:
P.Nandi,
K.Devore,
F.Wang,
S.Li,
J.D.Walker,
T.T.Truong,
M.G.Laporte,
P.Wipf,
H.Schlager,
J.Mccleerey,
W.Paquette,
R.C.A.Columbres,
T.Gan,
Y.P.Poh,
P.Fromme,
A.J.Flint,
M.Wolf,
D.M.Huryn,
T.F.Chou,
P.L.Chiu.
Mechanism of Allosteric Inhibition of Human P97/Vcp Atpase and Its Disease Mutant By Triazole Inhibitors. Commun Chem V. 7 177 2024.
ISSN: ESSN 2399-3669
PubMed: 39122922
DOI: 10.1038/S42004-024-01267-3
Page generated: Sat Sep 28 20:34:17 2024
|